Back

Comparative activity of moxifloxacin vs. trimethoprim-sulfamethoxazole, cloxacillin, linezolid, clindamycin, and ciprofloxacin against intracellular methicillin-sensitive and community-acquired methicillin-resistant S. aureus

Abstract number: 1733_201

Lemaire S., Van Bambeke F., Tulkens P., Glupczynski Y.

Objectives: Recurrence and persistence of S. aureus infection is often ascribed to intracellular bacterial persistence, which may also be a cause of emergence of resistance. We showed that the activity of antibiotics is always weaker when tested against intracellular bacteria in comparison to those growing in broth (AAC 2006, 50:841–851). In this context, we have examined the intraphagocytic activity of moxifloxacin (MXF; recently approved for skin and soft-tissues infections) against fully sensitive S. aureus (MSSA) and community-acquired methicillin-resistant S. aureus (CA-MRSA), in comparison with (i) antibiotics commonly used for the treatment of CA-MRSA infections (trimethoprim-sulfamethoxazole [TMP-SMX], cloxacillin [CLX], linezolid [LNZ], clindamycin [CLI]), and (ii) ciprofloxacin (CIP).

Methods: MSSA (ATCC 25923) and CA-MRSA (NRS 192) were used. MICs were determined by microdilution in MH broth according to CLSI guidelines with a 10e5 cfu/mL original inoculum. Intracellular activity was assessed on infected THP-1 macrophages (as described in details in AAC 2006, 50:841–851) after 24 h exposure to drug concentrations corresponding to their respective human Cmax (see Table). Controls cells (no antibiotic added) were incubated with gentamicin [0.5×MIC] to prevent extracellular growth (see validation in AAC 2006, 50: 841–851).

Results: The table shows the MICs of each drug, together with their corresponding intracellular activity (change in cfu from post-phagocytosis inoculum).

Drugs (Cmax*)ATCC 25923 (MSSA)NRS 192 (CA-MRSA)
MIC (mg/L)intracell. activity (D log cfu)MIC (mg/L)intracell. activity (D log cfu)  
TMP-SMX (25)1+0.6±0.11–2+0.7±0.0
CLX (8)0.125-0.8±0.10.5–1-0.07±0.1
LNZ (21)1-0.7±0.12-0.7±0.1
CLI (12)0.06-1.0±0.10.125-0.9±0.1
CIP (4)0.125-1.3±0.10.5-1.4±0.1
MXF (4)0.03-2.0±0.00.03-1.8±0.1
*As commonly observed in humans after conventional administration and used as extracellular concentration (total drug) to assess intracellular activity.

Conclusions: All antibiotics tested, with the exception TPM-SMX, allowed for a reduction of the intracellular inoculum, but MXF demonstrated the largest effect (~2 log decrease), but this could be due, partly, to its low MIC towards the strains examined.

Session Details

Date: 31/03/2007
Time: 00:00-00:00
Session name: European Society of Clinical Microbiology and Infectious Diseases
Subject:
Location: ICC, Munich, Germany
Presentation type:
Back to top